PGLYRP1 and arthritic joint disease: The anti-inflammatory function of PGLYRP-1 manifests itself only in the later stages of MDP-induced arthritis, which is consistent with the local release of PGLYRP-1 from PMN granules after PMNs' arrival into the mice foot [69].